With the public availability of ChatGPT 3.5 in fall 2022 at the latest, artificial intelligence in the sense of large language models (L LMs) is on everyone’s lips. However, it is often forgotten that this is only the provisional end point of decades of development of artificial intelligence, which, despite its great potential, still has many limitations. The question for practising doctors is how this technology can be used sensibly in everyday clinical practice – and how it should not be used.
Autoren
- Dr. med. Lukas Dürst
- Dr. med. Marc Oertle
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Artificial intelligence
Dr. ChatGPT: Large language models in everyday clinical practice
- Uncategorized
- Doing sport without fear or risk
Doing sport without fear or risk
- Chronic inducible urticaria
What has stayed the same, what has changed?
- Blastic plasmacytoid dendritic cell neoplasia
Rare malignancy from a dermatological perspective
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- Glomerulonephritis: IgA nephropathy
Pathogenesis-based and nephroprotective therapeutic approaches
- Case report: Acute rheumatic fever
ARF with myocarditis and occlusion of the RCA
- Internal thoracoscopy